Cancer vaccine eliminates metastases in first patient": According to reports, a Russian cancer vaccine helps the patient overcome the disease.
The first patient has already finished treatment. He is now being monitored, with tests carried out monthly. Andrey Kaprin, head of the National Radiological Medical Research Center of the Russian Ministry of Health and an academician, performs detailed CT scans with extremely high resolution, down to fractions of a millimeter.
"They mainly check the lymph nodes and scan the entire patient, from head to toe. It seems that four months have already passed, and everything is still fine. "As of yesterday, no new tumors have been detected," said Alexander Gintsburg, the scientific director of the Gamaliya National Research Center.
According to the academy, the patient is currently under medical supervision that will last three years.
The mRNA-based cancer vaccine is designed to train the patient's immune system to identify and destroy malignant tumors and metastases on its own. A personalized vaccine is developed for each patient based on their genetic data, as no two tumors are the same.